Claudio Bucolo

Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 181 publications

Off-label prescribing in ophthalmology: a retrospective analysis.

Off-label prescribing in ophthalmology: a retrospective analysis.

Journal: Frontiers in pharmacology

Published: March 23, 2026

Activity dependent neuroprotective protein mediates the protective effects against VEGF-induced corneal barrier disruption in diabetes.

Activity dependent neuroprotective protein mediates the protective effects against VEGF-induced corneal barrier disruption in diabetes.

Journal: Peptides

Published: February 26, 2026

Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools.

Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools.

Journal: Frontiers in pharmacology

Published: November 11, 2025

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Journal: Inflammation

Published: November 06, 2025

Safety profile of lutein-based blue dyes and surgical lights.

Safety profile of lutein-based blue dyes and surgical lights.

Journal: Frontiers in pharmacology

Published: September 12, 2025

Editorial overview: Advanced therapies and new targets in ocular diseases.

Editorial overview: Advanced therapies and new targets in ocular diseases.

Journal: Current opinion in pharmacology

Published: June 06, 2025

Safety and effectiveness of vital dyes for intraocular surgery.

Safety and effectiveness of vital dyes for intraocular surgery.

Journal: Progress in retinal and eye research

Published: February 22, 2025

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment.

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment.

Journal: Cell death & disease

Published: January 07, 2025

Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate.

Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate.

Journal: Frontiers in pharmacology

Published: December 19, 2024

α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells.

α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells.

Journal: International journal of molecular sciences

Published: December 16, 2024

Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomers.

Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomers.

Journal: Cell death discovery

Published: December 09, 2024

Retinal Protection of New Nutraceutical Formulation.

Retinal Protection of New Nutraceutical Formulation.

Journal: Pharmaceutics

Published: November 25, 2024

Showing 1-12 of 181

Last Updated: 09/26/2026